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An enormous array of adaptive mechanisms on both sides of the host-microbial interface reflects a complex coevolution. Deciphering the crosstalk at this interface may yield new insights into its relevance to health and disease. For example, Bar nich et al. 1 have recently described a host response to bacteria in patients with Crohn's disease.
A vast variety and number of microorganisms normally live within the human intestine. 2 The intestinal microbiome coexists with the intestinal immune system and is required for normal in testinal immune development and homeostasis. Several mechanisms prevent luminal bacteria, or specific subgroups thereof, from damaging the body or entering it in excessive numbers. These include a mucus layer, antimicrobial peptides, IgA, the epithelialcell barrier, immune cells within the intestine, and competition with other luminal bacteria. Disruption or imbalance of these protec tive components can result in inappropriate in testinal inflammation, as in Crohn's disease and ulcerative colitis (inflammatory bowel disease).
Investigators have long sought to identify a microorganism that causes inflammatory bowel disease; mycobacterial and yersinia species were past suspects but have not been proved guilty. At present, inflammatory bowel disease is believed to result from excessive intestinal immune acti vation that is driven by either luminal bacteria as a whole or perhaps particular bacterial subpop ulations. 3 In the host-microbial dialogue, proximity may be an important factor driving host responses. For instance, an increased number of adherent invasive Escherichia coli adhere to the ileal mucosa of patients with Crohn's disease. Increased bac terial adherence is not unique to Crohn's disease; various stresses, such as surgery and starvation, modify the characteristics of bacteria in the in testinal lumen, rendering them more adhesive to the intestinal mucosa. It is not clear whether the increased number of adherent invasive E. coli seen in patients with Crohn's disease is a primary or secondary event and to what extent it contributes to intestinal inflammation.
Barnich et al. have uncovered a mechanism by which adherent invasive E. coli interact with the epithelial cells of persons with Crohn's disease. They discovered that multiple strains of adherent invasive E. coli adhere far better to epithelial cells isolated from the ileum of persons with Crohn's disease than they do to cells of the same type isolated from unaffected persons. This suggests that there are specific alterations of the ileal epi thelial cells of persons with Crohn's disease that allow adherent invasive E. coli to adhere to a great er extent.
The authors discovered that type 1 pili -sur face organelles that are critical for maintaining the colonization of epithelial surfaces, especially those of the genitourinary and gastrointestinal tracts -of adherent invasive E. coli mediate the ability of the bacterium to adhere to ileal epithe lial cells. They then tried to identify the epithe lialcell molecule or molecules responsible for adherence. Mannose was found to diminish ad herence, thus implicating a mannosecontaining glycoprotein.
Of the various candidate proteins known to enable bacterial adhesion, both carcinoembry onic antigen-related celladhesion molecule 6 (CEACAM6) and CEACAM5 are overexpressed in the ileal epithelial cells of patients with Crohn's disease, as compared with those of controls. Bar nich et al. showed that this upregulation occurs in both inflamed and noninflamed regions of the ileum, but not in the colon.
The investigators then found that adherent in vasive E. coli lost their adherence to enterocytes in patients with Crohn's disease only after the block ade of CEACAM6. Moreover, the presence of ad herent invasive E. coli causes an increase in the expression of CEACAM6 on the surface of cultured intestinal cells, as does incubation with inter feronγ or tumor necrosis factor α (TNFα), pro inflammatory mediators of which increased lev els are typically found in the intestine of patients with Crohn's disease. The same group of inves tigators had previously shown that adherent in vasive E. coli can induce the secretion of TNFα from cultured macrophages. 4 Therefore, adherent invasive E. coli may directly and indirectly induce epithelial cells to upregulate CEACAM6, there by enabling their own adhesion to these cells (Fig. 1 ).
An elevated level of CEACAM6 expression may turn out to be a marker of increased levels of in flammatory cytokines in the absence of inflam mation on endoscopic or histologic examination, although its degree of specificity will need to be assessed.
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